Visalytics
Visalytics
approved EB-2 (NIW)

Instructor

Biomedical Science · Hong Kong · 2022-08-23

Processing Time
446 days
Decision Date
2022-08-23
Location
Illinois
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue research on the behavior of the immune system in skin cancers and identify new mutations that drive their formation. This work aims to develop new therapies against cancer, specifically focusing on molecular mediators of breast cancer metastasis and treatments for autoimmune and inflammatory bowel diseases.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research was found relevant to cancer research, autoimmune disease treatment, and public health worldwide.

2 Well-positioned to Advance the Endeavor Met

The petitioner demonstrated success through 13 publications, 298 citations, and 5 major financial aid awards from the NIH.

3 Waiver of Job Offer and Labor Certification Met

On balance, the petitioner's contributions to biomedical science and public health justified the waiver of the labor certification.

Why This Petition Was Approved

The petition was approved based on 13 peer-reviewed journal articles (4 first-authored) published in 10 high-ranking journals, which accumulated 298 citations. The petitioner also secured 5 major financial grants from institutions like the NIH and NIDDK, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Original Contributions
Government Alignment

Similar Cases

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
California 467 days 2025-02-25
The petitioner proposes to continue identifying and characterizing novel genes and pathways that influence tumor cell behavior. Her work focuses on improving the understanding of cancer pathogenesis and immunotherapy to accelerate the development of new therapeutic strategies.
View Case

Research Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
California 354 days 2025-04-03
The petitioner proposes to advance the identification of new therapeutic targets for cancer, autoimmune diseases, and chronic inflammatory conditions using high-throughput technologies like single-cell sequencing. Her work focuses on examining T cell behavior within tumor microenvironments and immune responses to vaccines and cancer treatments to develop cost-effective strategies for immune modulation.
View Case

Postdoctoral Researcher

Biotechnology · Mexico

WeGreened EB-2 (NIW) approved
Maryland 489 days 2022-08-22
The petitioner proposes to develop a highly quantitative understanding of the interactions between cancer cells and the immune system. He utilizes high-resolution microscopy, high-throughput flow cytometry, and mathematical modeling to design personalized cancer immunotherapies that are more effective than current treatments.
View Case

Assistant Professor

Healthcare · Pakistan

WeGreened EB-2 (NIW) approved
District of Columbia 3 days 2023-08-23
The petitioner proposes to continue her research in pathology with a focus on molecular pathology and personalized treatment strategies for breast and genitourinary cancers. Her work involves developing tissue microarray analysis techniques to extract genomic and immunohistochemical data for more accurate cancer diagnostics. She also aims to discover molecular markers for rare and treatment-resistant tumors, particularly in underserved populations.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Hong Kong

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-08-23.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 446 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Hong Kong All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist